Showing results (2351-2360 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|November 29, 2011
Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese populationChung-Ching Wang, Wei-Liang Chen, Tung-Wei Kao, et al.Clinical Therapeutics|November 15, 2011
Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009Michael J DowzickyClinical Therapeutics|November 15, 2011
Pharmacokinetics and tolerability of nasal versus intravenous midazolam in healthy Dutch volunteers: a single-dose, randomized-sequence, open-label, 2-period crossover pilot studyNicole M L Veldhorst-Janssen, Audrey A A Fiddelers, Paul-Hugo M van der Kuy, et al.Clinical Therapeutics|August 16, 2011
Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depressionYonghua Jing, Iftekhar Kalsekar, Suellen M Curkendall, et al.Clinical Therapeutics|August 16, 2011
Bioequivalence of two tacrolimus formulations under fasting conditions in healthy male subjectsPhilip Mathew, Jayanta Mandal, Kamlesh Patel, et al.Clinical Therapeutics|January 28, 2012
Pharmacokinetic comparison of 2 formulations of anastrozole (1 mg) in healthy Korean male volunteers: a randomized, single-dose, 2-period, 2-sequence, crossover studyYook-Hwan Noh, Young-Ju Ko, Sang-Heon Cho, et al.Clinical Therapeutics|February 21, 2012
Pazopanib for the treatment of metastatic renal cell carcinomaAmy M Pick, Kelly K NystromClinical Therapeutics|January 18, 2012
Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose studyJay Purdy, Sylvie Jouve, Jean Li Yan, et al.Clinical Therapeutics|July 1, 1990
Effects of a new calcium channel blocker, TA 3090, on serum lipoprotein levels in mild to moderate essential hypertensionJ Sasaki, M Ideishi, K Saku, et al.Clinical Therapeutics|July 1, 1990
Nicardipine in the prevention of cerebral infarctionJ F Martí Massó, R LozanoPageof 680